New work promises to shed more light on processes whereby bacteria re able to resist drugs and may ultimately contribute towards the search for new treatments for bacterial diseases.
Although the lungs are thought to be the replication site for SARS-CoV-2, infected patients often report other symptoms, suggesting problems with the gastrointestinal tract, heart, cardiovascular system, kidneys, nervous system or pancreas. This raises the question: is COVID-19 a respiratory or systemic disease? How is this possible? Please read about the new study by the ViroGenetics Group led by Prof. Krzysztof Pyrć.
Dr Przemysław Grudnik from the Małopolska Centre of Biotechnology of the Jagiellonian University (JU MCB) was awarded the Polish Intelligent Development Award 2020 in the Scientist of the Future category. He was recognised for his research on molecular mechanisms controlling the protein synthesis process and on the structures of enzymes involved in neoplastic processes.